naltrexone has been researched along with Gambling in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (6.06) | 18.2507 |
2000's | 16 (48.48) | 29.6817 |
2010's | 12 (36.36) | 24.3611 |
2020's | 3 (9.09) | 2.80 |
Authors | Studies |
---|---|
Bowden-Jones, H; Cowlishaw, S; Dowling, N; Lubman, D; Merkouris, S; Thomas, S | 1 |
Etuk, R; Kraus, SW; Potenza, MN | 1 |
Bäckström, P; Kiianmaa, K; Oinio, V; Piepponen, P; Raasmaja, A; Sundström, M; Uhari-Väänänen, J | 1 |
Lee, JC; Takayesu, AG | 1 |
Benyamina, A; Hamzaoui, S; Kebir, O; Laqueille, X; Leite, C; Mouaffak, F | 1 |
Bowden-Jones, H; Smith, N; Ward, S | 1 |
Kim, SW; Yoon, G | 1 |
Bartley, CA; Bloch, MH | 1 |
Alho, H; Basnet, S; Castrén, S; Kovanen, L; Lahti, T; Pankakoski, M; Partonen, T; Saarikoski, ST | 1 |
Fontenelle, LF; Piquet-Pessôa, M | 1 |
Dowling, NA; Lorains, FK; Merkouris, SS | 1 |
Di Ciano, P; Le Foll, B | 1 |
Allen, AR; Balleine, B; Carter, A; Clark, L; Dowling, NA; Gainsbury, SM; Goudriaan, AE; Grant, J; Hall, W; Hayes, A; Hodgins, D; Lattimore, R; Livingstone, C; Lorenzetti, V; Lubman, D; Murawski, C; Parkes, L; Petry, N; Room, R; Singh, B; Thomas, A; Townshend, P; van Holst, R; Youssef, G; Yücel, M | 1 |
Grant, JE; Hollander, E; Kim, SW; Potenza, MN | 1 |
Blanco, C; Grant, JE; Hollander, E; Kim, SW; Potenza, MN | 1 |
Grant, JE; Hollander, E; Kim, SW; Odlaug, BL; Potenza, MN | 1 |
Bowden-Jones, H; George, S | 1 |
Grant, JE; Grosz, RL; Kim, SW | 1 |
Ladoceur, R; Toneatto, T | 1 |
Grant, JE; Grosz, R | 1 |
Baker, B; Baldini-Rossi, N; Hollander, E; Pallanti, S; Sood, E | 1 |
Dannon, PN; Gonopolski, Y; Kotler, M; Lowengrub, K; Musin, E | 1 |
Nestler, EJ; Tamminga, CA | 1 |
Cunningham-Williams, R; Grant, JE; Hollander, E; Kallio, A; Nurminen, T; Potenza, MN; Smits, G | 1 |
Arnestad, HM; Holsten, F; Iversen, E; Kvale, G; Laberg, JC; Molde, H; Pallesen, S; Skutle, A; Støylen, IJ | 1 |
Dannon, PN; Gonopolsky, Y; Kotler, M; Lowengrub, K; Musin, E | 1 |
Grant, JE; Hartman, BK; Kim, SW | 1 |
Crockford, DN; el-Guebaly, N | 1 |
Kim, SW | 1 |
Buchalter, AJ; DeCaria, CM; Hollander, E | 1 |
Adson, DE; Grant, JE; Kim, SW; Shin, YC | 1 |
Grant, JE; Kim, SW | 2 |
11 review(s) available for naltrexone and Gambling
Article | Year |
---|---|
Pharmacological interventions for the treatment of disordered and problem gambling.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Gambling; Headache; Humans; Naltrexone; Narcotic Antagonists; Nausea; Olanzapine | 2022 |
Current pharmacotherapy for gambling disorder: a systematic review.
Topics: Behavior, Addictive; Diagnosis, Dual (Psychiatry); Gambling; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Randomized Controlled Trials as Topic; Substance-Related Disorders | 2020 |
Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Behavior, Addictive; Gambling; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic | 2017 |
Meta-analysis: pharmacological treatment of pathological gambling.
Topics: Antipsychotic Agents; Gambling; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2013 |
Opioid antagonists in broadly defined behavioral addictions: a narrative review.
Topics: Alcoholism; Bulimia; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Trichotillomania | 2016 |
Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research.
Topics: Acetylcysteine; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Bipolar Disorder; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Free Radical Scavengers; Gambling; Humans; Lithium Compounds; Mental Disorders; Motivational Interviewing; Naltrexone; Narcotic Antagonists; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Tobacco Use Disorder | 2016 |
Neuroscience in gambling policy and treatment: an interdisciplinary perspective.
Topics: Administrative Personnel; Appetite Depressants; Decision Making; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Harm Reduction; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neurosciences; Public Health | 2017 |
Treatment of pathological gambling: a critical review of the literature.
Topics: Behavior, Addictive; Cognitive Behavioral Therapy; Fluvoxamine; Gambling; Guidelines as Topic; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Self-Help Groups | 2003 |
Pharmacological treatments of pathological gambling.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Fluvoxamine; Gambling; Humans; Naltrexone; Outcome Assessment, Health Care; Paroxetine; Piperazines; Research Design; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Triazoles | 2005 |
Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis.
Topics: Antidepressive Agents; Antimanic Agents; Gambling; Humans; Models, Statistical; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Psychotropic Drugs; Regression Analysis | 2007 |
Pathological gambling.
Topics: Cognitive Behavioral Therapy; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Male; Mental Disorders; Naltrexone; Narcotic Antagonists; Residential Treatment; Selective Serotonin Reuptake Inhibitors; Self-Help Groups | 2000 |
8 trial(s) available for naltrexone and Gambling
Article | Year |
---|---|
A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
Topics: Adult; Aged; Combined Modality Therapy; Double-Blind Method; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Polymorphism, Single Nucleotide; Psychotherapy, Brief; Receptors, Opioid, mu; Treatment Outcome; Young Adult | 2016 |
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling.
Topics: Adult; Age Factors; Aged; Alcoholism; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gambling; Humans; Logistic Models; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Predictive Value of Tests; Psychometrics; Severity of Illness Index; Treatment Outcome; Young Adult | 2008 |
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Follow-Up Studies; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Personality Inventory; Psychometrics; Reproducibility of Results | 2009 |
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gambling; Humans; Intention to Treat Analysis; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Treatment Outcome; United States; Young Adult | 2010 |
Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.
Topics: Adult; Bupropion; Cohort Studies; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Single-Blind Method; Socioeconomic Factors; Treatment Outcome | 2005 |
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Topics: Adult; Age of Onset; Ambulatory Care; Behavior, Addictive; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drugs, Investigational; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2006 |
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
Topics: Adolescent; Adult; Aged; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists | 2008 |
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
Topics: Adolescent; Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Gambling; Humans; Interview, Psychological; Liver Function Tests; Middle Aged; Naltrexone; Narcotic Antagonists; Single-Blind Method; Surveys and Questionnaires | 2001 |
14 other study(ies) available for naltrexone and Gambling
Article | Year |
---|---|
The role of opioidergic system in modulating cost/benefit decision-making in alcohol-preferring AA rats and Wistar rats.
Topics: Alcohol Drinking; Analgesics, Opioid; Animals; Behavior, Animal; Cost-Benefit Analysis; Decision Making; Gambling; Male; Morphine; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Sucrose | 2021 |
Gambling Disorder and Concurrent Alcohol Use Disorder Treated With Naltrexone.
Topics: Adult; Alcoholism; Depressive Disorder; Gambling; Humans; Male; Naltrexone; Narcotic Antagonists | 2017 |
The use of naltrexone in pathological and problem gambling: A UK case series.
Topics: Adult; Craving; Female; Follow-Up Studies; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Problem Behavior; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United Kingdom | 2018 |
Monthly injectable naltrexone for pathological gambling.
Topics: Drug Administration Schedule; Gambling; Humans; Injections, Intramuscular; Male; Medication Adherence; Middle Aged; Naltrexone | 2013 |
Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder.
Topics: Analysis of Variance; Animals; Behavior, Animal; Choice Behavior; Decision Making; Disease Models, Animal; Gambling; Male; Naltrexone; Narcotic Antagonists; Rats | 2016 |
Gambling addiction.
Topics: Adult; Antimanic Agents; Behavior Control; Behavior, Addictive; Gambling; Humans; Male; Naltrexone; Narcotic Antagonists; Psychological Techniques; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Self-Help Groups; Treatment Outcome | 2011 |
Pathological gambling. Current status and new treatments.
Topics: Behavior, Addictive; Dose-Response Relationship, Drug; Drug Administration Schedule; Gambling; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors | 2002 |
Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation.
Topics: Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Humans; Male; Middle Aged; Naltrexone; Personality Assessment; Phobic Disorders; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
Pathological gambling: focusing on the addiction, not the activity.
Topics: Behavior, Addictive; Gambling; Humans; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Receptors, Opioid; Substance-Related Disorders; Treatment Outcome | 2006 |
12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
Topics: Adolescent; Adult; Analysis of Variance; Bupropion; Delayed-Action Preparations; Drug Therapy; Fluvoxamine; Follow-Up Studies; Fructose; Gambling; Humans; Israel; Male; Middle Aged; Naltrexone; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychopharmacology; Recurrence; Reproducibility of Results; Surveys and Questionnaires; Time Factors; Topiramate | 2007 |
Naltrexone in the treatment of pathological gambling and alcohol dependence.
Topics: Alcoholism; Combined Modality Therapy; Comorbidity; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists | 1998 |
Opioid antagonists in the treatment of impulse-control disorders.
Topics: Adult; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists | 1998 |
An open naltrexone treatment study in pathological gambling disorder.
Topics: Adolescent; Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Gambling; Humans; Male; Middle Aged; Motivation; Naltrexone; Personality Assessment; Psychiatric Status Rating Scales; Treatment Outcome | 2001 |
Demographic and clinical features of 131 adult pathological gamblers.
Topics: Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Gambling; Humans; Male; Middle Aged; Motivation; Naltrexone; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Socioeconomic Factors | 2001 |